NXP - Latest News

Nuveen Select Tax-Free Income Portfolio (NXP), operates in Financial Services / Asset Management - Income, trades on NYSE.

Market capitalization stands near $751.0M.

The article list below shows the most recent NXP headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent NXP Headlines

StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data

newsfilecorp.com - Jul 14, 2026

New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncology story into a late-stage rare-disease player fo

NXP Semiconductors: Why I Think The Valuation Discount Is Too Harsh

seekingalpha.com - Jul 8, 2026

I rate NXP Semiconductors a buy with a $470 price target, implying 68% upside from current levels of $280. The biggest growth driver is automotive, w

NXP Semiconductors Announces Conference Call to Review Second Quarter 2026 Financial Results

globenewswire.com - Jul 7, 2026

EINDHOVEN, The Netherlands, July 07, 2026 (GLOBE NEWSWIRE) -- NXP Semiconductors N. V.

NXP Semiconductors: Too Cheap Ahead Of Earnings

seekingalpha.com - Jul 6, 2026

NXP Semiconductors is rated a Buy ahead of Q2 earnings, with valuation looking attractive versus peers despite improved fundamentals. NXPI's Q1 deliv

What NXP Looks Like Post Merger: Now Buy Rated

seekingalpha.com - Jul 3, 2026

Nuveen Select Tax-Free Income Portfolio completed its merger with California and New York single-state funds, increasing AUM to $900MM. NXP maintains

Frequently asked NXP news questions

What is the latest NXP news headline?
The most recent NXP headline (Jul 14, 2026) is "StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the NXP news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What NXP news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual NXP options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.